Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51. - Test2 - elhamkhani - TriplyDB

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.

http://www.wikidata.org/entity/Q39093643

about

Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation FKBP51 and FKBP52 in signaling and disease Immunoregulatory functions of mTOR inhibition.Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.Cell therapy using tolerogenic dendritic cells in transplantation.Dendritic Cells and Macrophages: Sentinels in the Kidney.FK506 binding protein 51 integrates pathways of adaptation: FKBP51 shapes the reactivity to environmental change.Tolerogenic dendritic cell therapy in organ transplantation.Interferon regulation factor-3 is a critical regulator of the mature of dendritic cells from mice.Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin.

P2860

Q21135500-3B45BAF2-10B9-4563-B273-3B0B1D4D5EC3 Q21284774-7C8B5572-1A19-48CE-B781-D05604D5D12A Q26861304-8012284B-BAF2-4AF6-92D9-43D4FB66A8F4 Q33761278-DF1ECB7F-FFC6-43F6-9555-AD153E6C85BC Q34482931-C2BC2211-1CDE-4379-B2DA-37992489BFEC Q35241354-D4A4C344-BA04-46F0-B0ED-C28E435C0E98 Q37206430-744D6EEF-CA79-441B-A391-7F3BA268542E Q38078105-013A81F1-A272-4A42-9C46-67C1AA1C86FA Q38310937-16961E16-522E-4523-B082-981E6AD2A28F Q38885066-09D35E5D-FECE-4E31-9B0B-827251D918F1 Q39013872-3DBD6FDC-3D72-463A-A0BA-038572F7D344 Q44393094-FC01B356-B287-41D7-9DB9-22B04F443F53 Q47204087-E393599A-C5D8-4B54-A9CB-D26E39BDDE4E

P2860

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.

http://www.wikidata.org/entity/Q39093643

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Inhibition of endogenous MHC c ...... tacrolimus (FK506) via FKBP51.

@en

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus

@nl

type

label

Inhibition of endogenous MHC c ...... tacrolimus (FK506) via FKBP51.

@en

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus

@nl

prefLabel

Inhibition of endogenous MHC c ...... tacrolimus (FK506) via FKBP51.

@en

Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus

@nl

P1433

Q39093643-79192BBE-EE37-4194-BF0C-60AC125B7E19

P1476

Q39093643-532008AC-D1BD-48B0-B20B-69F74690C168

P2093

Q39093643-0BA9F131-B597-427B-A282-761D452EC7E5

Q39093643-40DF07B7-AF3E-4547-A1E4-DC30B8235AE9

Q39093643-8DB7E033-1CF8-4085-86F5-76338C842123

Q39093643-AA4E0719-D34E-4761-87E3-0C337C339BB2

Q39093643-E380E51F-C163-4573-A28C-84F22B32B13B

Q39093643-E8B8CC88-9391-41FD-9C66-824EBF2AED27

Q39093643-F09766A9-E313-4EE8-9456-4B3ACF7A0D7A

Q39093643-FE5148B6-5A4E-4AEC-9FEB-A2A572F71909

P2860

Q39093643-0548F948-6227-4D31-8124-4B1ED8CFB4EB

Q39093643-0AC15588-7F3F-4B4A-B6E8-5F630464C5C3

Q39093643-0FD4C8B5-3E3C-4FEC-AAFE-4268428AE77E

Q39093643-145930CF-85D3-43EA-B05A-206322079156

Q39093643-2E49D98F-97AD-40F0-B991-B81D48EFEA95

Q39093643-482FB13A-368B-4D79-BDDB-E121B5BDD60C

Q39093643-4B91ECCB-A8AD-49BC-A600-7B8F0A965168

Q39093643-4FCF05A7-50F2-40C6-81EB-1BE60E869307

Q39093643-558565AC-CFCF-4EA0-A794-978BFAFA63CC

Q39093643-5B4DBEF1-14EB-4590-A15C-7343763809B0

P304

Q39093643-1E2100FD-7FE0-480D-875D-E84AD3566C60

P31

Q39093643-3A7E64F8-177C-4C82-BF6F-8EC71033355C

P356

Q39093643-DEBC8379-E5D4-4F36-BA44-42DCC8334868

P407

Q39093643-7EF29105-471E-40D8-A986-B6A18298ECF9

P433

Q39093643-FEA0F1E4-A846-4173-9C45-592094DF185B

P478

Q39093643-76326C12-31FF-4D30-B149-DFE8B1ABA474

P577

Q39093643-AD5D332A-5ECA-4DEB-B91C-13255192383C

P5875

Q39093643-A7235528-858B-48DC-A012-A8ACE2212C89

P698

Q39093643-04251039-BC82-4B51-8F97-E225D1F607BF

P356

P1433

European Journal of Immunology

P1476

Inhibition of endogenous MHC c ...... tacrolimus (FK506) via FKBP51.

@en

P2093

Akihito Imai

http://www.w3.org/2001/XMLSchema#string

Hiroeki Sahara

http://www.w3.org/2001/XMLSchema#string

Kowichi Jimbow

http://www.w3.org/2001/XMLSchema#string

Kyori Ezoe

http://www.w3.org/2001/XMLSchema#string

Noriyuki Sato

http://www.w3.org/2001/XMLSchema#string

Takatoshi Yotsuyanagi

http://www.w3.org/2001/XMLSchema#string

Tamotsu Saito

http://www.w3.org/2001/XMLSchema#string

Yasuaki Tamura

http://www.w3.org/2001/XMLSchema#string

P2860

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin

Localization and function in endoplasmic reticulum stress tolerance of ERdj3, a new member of Hsp40 family protein

Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins

Steroid receptor interactions with heat shock protein and immunophilin chaperones

P304

1730-1738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.200636392

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6309951

http://www.w3.org/2001/XMLSchema#string

P698

17523132

http://www.w3.org/2001/XMLSchema#string